Double unit cord blood (CB) transplantation (CBT) appears to augment engraftment despite only one unit engrafting in most patients. We hypothesized that superior unit quality, as measured by a higher percentage of viable cells postthaw, would determine the engrafting unit. Therefore, we prospectively analyzed 46 double-unit transplants postthaw using flow cytometry with modified gating that included all dead cells. Using a 75% threshold (mean viability minus 2 SD), 20% of units had low CD34+ cell viability, with viability varying according to the bank of origin. Further, in the 44 patients with single unit engraftment, CD34+ cell viability was higher in engrafting units (P=.0016). Although either unit engrafted if both had high CD34+ viabil...
BackgroundUmbilical-cord blood has been used as the source of hematopoietic stem cells in an estimat...
AbstractCord blood (CB) and autologous mobilized peripheral blood stem/progenitor cells (PBSC) are n...
Expansion of haemopoietic stem cells is proposed to combat graft failure in adult recipients followi...
Cord blood transplantation (CBT) is a promising alternative means of allogeneic stem cell transplant...
AbstractSustained hematopoiesis after double-unit cord blood transplantation (dCBT) is mediated by 1...
AbstractThe quantity of cells is widely accepted as the main factor influencing the outcome after um...
AbstractUmbilical cord blood (UCB) transplantation is limited by the low number of hematopoietic ste...
Cord Blood Units (CBU) are increasingly used for allogeneic stem cell transplant and their selection...
AbstractSingle cord blood unit (CBU) predominance is usually established within the first month afte...
Graft failure occurs in approximately 20% of patients after unrelated umbilical cord blood transplan...
Cord blood transplantation (CBT) with units containing total nucleated cell (TNC) dose >2.5 × 107/kg...
The transplantation of two cord blood (CB) units obtained from unrelated donors (double CBT) is an e...
The inability to obtain additional stem cells is a disadvantage of unrelated donor cord blood transp...
AbstractSingle-donor dominance is observed in the majority of patients following double-unit cord bl...
AbstractUmbilical cord blood (CB) from unrelated donors is increasingly used to restore hematopoiesi...
BackgroundUmbilical-cord blood has been used as the source of hematopoietic stem cells in an estimat...
AbstractCord blood (CB) and autologous mobilized peripheral blood stem/progenitor cells (PBSC) are n...
Expansion of haemopoietic stem cells is proposed to combat graft failure in adult recipients followi...
Cord blood transplantation (CBT) is a promising alternative means of allogeneic stem cell transplant...
AbstractSustained hematopoiesis after double-unit cord blood transplantation (dCBT) is mediated by 1...
AbstractThe quantity of cells is widely accepted as the main factor influencing the outcome after um...
AbstractUmbilical cord blood (UCB) transplantation is limited by the low number of hematopoietic ste...
Cord Blood Units (CBU) are increasingly used for allogeneic stem cell transplant and their selection...
AbstractSingle cord blood unit (CBU) predominance is usually established within the first month afte...
Graft failure occurs in approximately 20% of patients after unrelated umbilical cord blood transplan...
Cord blood transplantation (CBT) with units containing total nucleated cell (TNC) dose >2.5 × 107/kg...
The transplantation of two cord blood (CB) units obtained from unrelated donors (double CBT) is an e...
The inability to obtain additional stem cells is a disadvantage of unrelated donor cord blood transp...
AbstractSingle-donor dominance is observed in the majority of patients following double-unit cord bl...
AbstractUmbilical cord blood (CB) from unrelated donors is increasingly used to restore hematopoiesi...
BackgroundUmbilical-cord blood has been used as the source of hematopoietic stem cells in an estimat...
AbstractCord blood (CB) and autologous mobilized peripheral blood stem/progenitor cells (PBSC) are n...
Expansion of haemopoietic stem cells is proposed to combat graft failure in adult recipients followi...